ChitogenX. is an orthopedic biotechnology company.
ChitogenX has raised $2.5M in total funding. The most recent round was Post-IPO Equity. The last funding was announced in April 2023.
ChitogenX's investors include Natural Sciences and Engineering Research Council of Canada (NSERC), Axelys.
ChitogenX is headquartered in Quebec, Canada.
ChitogenX. is an orthopedic biotechnology company.
ChitogenX is at the Post-IPO Equity stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"ChitogenX — Funding & Investors." VCBacked, April 4, 2023, https://www.vcbacked.co/company/chitogenx. Accessed September 30, 2026.
VCBacked. (2023). ChitogenX — Funding & Investors. Retrieved September 30, 2026, from https://www.vcbacked.co/company/chitogenx
{{cite web |title=ChitogenX — Funding & Investors |url=https://www.vcbacked.co/company/chitogenx |website=VCBacked |access-date=September 30, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated